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;SUMMARY AND GENEML DISCUSSION
Although studied for some time now, the pathophysrology of antineutrophil
cytoplasm autoantibody (ANCA)-associated systemic vascul-itis still temains a held of
research with many unresolved questions. Thrs gtoup of di.seases, manifesting as
inflammation of small blood vessels, includes Wegener's gtanulomatosis fWG) and
microscopic polyangiius MPA), characterized by ANCA speciFrc for proteinase 3
(PR3) and myeloperoxidase Gv{PO), respectively. Anti-PR3 and antr-MPO
autoantibodies have become an established and specrfic marker fot WG and MPA,
respectively, and their detection is helpful in both diagnosis and in follow-up of
patients wrth systemic vasculitjs. Several cltnical observations suggest that ANCA
may be involved in the disease pathogenesis. First, an increase in ANCA trter
frequently precedes a relapse and titers decline when the patient comes into
remission. Second, persistent presence of PR3-ANCA after induction of remission
has been found to be associated with an incteased risk to develop relapses. Thirdly,
development of relapses can be succesfully prevented using ANCA titer-based
treatment. Despite this close association between ANCA titers and disease activity,
the effector role o[ PR3-ANCA in the pathophysiology of WG has not been fully
elucidated yet. Nevertheless, thete is evidence that ANCA are not only an
epiphenomenon associated with systemic vasculitis, but may conffibute directly to
the occurence of vascular and glomerular lesions. In aitro studies have demonstrated
that PR3-ANCA are capable of cross-linking PR3 and Fc1 receptors exptessed on
the neutrophil surface resulting in ptoduction of reactive oxygen species and the
telease of proteolytic enzymes, including PR3 and elastase. Subsequently, this may
lead to detachment, cytolysis, and apoptosis of endothelial cells. To some extent,
endothelial cell injury is dependent on the proteolytic activity of PR3 which, in
normal conditions, should be inactivated by physiologrcal inhibitots of PR3 such as
clr-antitry?sin (ctr-AT). Interestingly, PR3-ANCA has been shorvn to interfere with
binding of crr-AT to PR3 which may prevent PR3 from this inhibition to display its
full proteolytrc actrvity. Thrs functional charactenstic of PR3-ANCA correlates with
disease activity of WG, suggesting that intra-individual changes of PR3-ANCA on
the epitope level occur during the time course of the disease.
In this thesis we addressed five questions emerging from the observations mentioned
above. The hrst fwo concern the importance of the accessibility of PR3 for PR3-
ANCA binding and neutrophil activation. First: does the level of PR3 expression on
the surface of resting neutrophils determine the susceptibilrty of patients wrth WG to
develop relapses? Second: is the level of PR3 present on the cell surface related to
the extent of neutrophil activation by PR3-ANC A in uitro? The other three questions
concern the interactions berween PR3-ANCA and its tatget antigen at the eprtope
141
CHAPTER 8
level. Is there any inter-individual variability in PR3-ANCA epitope specificiry at the
moment of presentation of the disease? Does PR3-ANCA epitope speciFrciry change
dudng the time course of the disease withrn an individual? What can we learn about
the epitopes recognized by PR3-ANCA using a recombinant form of PR3?
In Chapter 2 we summaize the literature contributing to our current view on the
pathophysiology of ANCA-associated vasculitis. We review evidence for a phlogrstrc
effect of ANCA that has emerged from clinical observations, in uitro studies, and z7
uiuo experknental animal models. Next, rve address the role of exogenous factors
possibly involved in disease iruuation and ptogtession, such as Staphllococcar- a/./re/.t!
and exposure to silica. We also mention genetic factors that may determine the
susceptrbility of an indtvidual to develop ANCA-associated vasculitis. Shortly, in this
chapter we tried to put together all the factors participating in disease development
and stress the fact that ANCA-associated vasculitides are complicated autoimmune
disorders in which the rnterplay of autoimmunity with genetic and environmental
factors determines their clinical exDression.
The detection of PR3-ANCA by the indirect immunofluorescence assay (IIF) is an
established diagnostic tool for patients with WG. Due to several drawbacks, such as
lack of antigen-speciFrciry and inaccurate quantification, the IIF assay is usually
perfotmed in combination wrth PR3-specific solid-phase assays (PR3-ELiSA). This
technique is antigen specihc and gives precise information on the PR3-ANCA titers.
Most ELISA systems for PR3-ANCA detection use native PR3 isolated from human
neutrophils or a crude extract of neutrophil granules as an antigen source. Since the
isolation of highly purified PR3 from neuttophils is laborious, difficult and
inefFtcient, an altemative for purified native PR3 is the use of recombinant PR3. In
Chapter 3 we compare the technical performance of direct and capture ELISA using
native PR3 and a novel proteolytrcally inactive recombinant PR3 produced rn the
baculovirus expression system to detect PR3-ANCA in patients with systemic
vasculitis at the moment of diagnosis. The use of ptoteolltically inactive PR3 can be
advantageous for the stabrJrty and reliability of an ELISA, since proteolytically active
PR3 is able to degtade both the capruring monoclonal anubody and patrent PR3-
ANCA. Our study shows that the sensitivity of ELISA applylng this tecombinant
PR3 is comparable to the sensitivity of ELISA using native PR3. Therefore,
baculovirus PR3 is a promising altemative for native PR3 for the detection of PR3-
ANCA. Flowevet, we suggest that the specifictty of the assays using recombinant
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PR3 should be futher improved. Moreover, better validation of the test requires the
intoduction of a new, improved, standatd.
Capture ELISA not only can be used as a diagnostic method, but it may also provide
information on the epitope speciFrcity of PR3-ANCA, when capturing antibodies of
different epitope specificities are used. In our study, we applied two capture antr-PR3
antibodies, 12.8 and PR3G-3, which are known to recognize different epitopes on
the PR3 molecule. Recombinant PR3 was more frequently recognized by patient sera
when captured by MAb PR3G-3, suggesting that MAb 12.8 might interfere with
binding of some PR3-ANCA. Although, in capture ELISA using MAb 12.8, native
PR3 performed better compared to recombinant PR3, this diffetence was not
present when I\{-A.b PR3G-3 was used, further demonstrating the implications of the
choice of the capturing anubody for the results of the assay. Moreovet, it cannot be
excluded that epitopes present on the recombinant bacuiovirus PR3 are not identical
to the epitopes on native PR3.
We conclude that baculovirus PR3 is a promissing altetnative for PR3 isolated ftom
human neutophils and, in the future, can be of value for diagnostic app)ications.
Nevertheless, futther optimizing of sensiuvity and specificity of ELISA using this
recombinant antigen is necessary, as well as development of a suitable val-idation
standard.
Several attempts have been made to characterjze the interactions between ANCA
and PR3 and it has been demonstrated that PR3-ANCA mainly recognize
conformational epitopes on PR3. One of these studies showed that monoclonal
antibodies raised against PR3 recognize fout separate areas on this protein,
suggesting that there could also be a vadability in epitope specificity of PR3-ANCA
from patients with WG. However, up to now, knowledge on the epitopes for PR3-
ANCA has been scarce. In Chapter 4, we describe a study using the biosensor
technoiogy to investigate possible variability in epitope specificiry of PR3-ANCA of
WG pauents at the moment of disease ptesentation. Performing mutual inhibiuon
experiments, we found that, at the moment of diagnosis of WG, PR3-ANCA of
different patients recognize a limrted numbet of ovedapping regions on PR3. This
area seems to cover an immunodominant epitope, cofirnon for PR3-ANCA from all
patients, irrespective of the size of the total area recognb,ed by an individual
autoantibody. These results are similar to the results of comparable experiments




The second question addressed in our study was whether epitope specihciry- of PR3-
ANCA wrthin a patient is stable in time. Experiments with sera collected at the
moment of disease presentation and at the time of relapse show that the indrvidual
epitope specihcity of PR3-ANCA may change duting the course of the disease, a
phenomenon known as epitope shift. Epitope shift has recendy been tecognized as
an important pathogenic mechanism responsible for the iruuation and progtession of
autoimmune diseases, for instance systemic lupus erythematosus (SLE). Intra-
individual changes in PR3-ANCA epitope speciFrcity may reflect B-cell epitope
spreading from a disease-inducing epitope to other areas of the autoantigen (intra-
molecular epitope spreadrng). Moreover, changes of epitope specificity of PR3-
ANCA during the course of the disease may be tesponsible for differences in
functional ptoperties of these autoantibodies between various stages of the disease.
One of these properties is the ability of PR3-ANCA to interfere wrth the proteolytic
activitl' of PR3 and with binding of the physiologic PR3 inhibitor, or-antitqpsir (cr,-
AT), to PR3. The number of patients rncluded in thrs part of the study was very
small and, therefore, our observation should be further conhrmed in a larger gtoup
of patients. To characterize these changes in more detail, analysis of PR3-ANCA
specihcrty at the ume of other relapses as well as dudng remission should be
performed.
An addrtional important observation from our study is the fact that epitope
speciFrcity of polyclonal rabbit anti-PR3 antibodies is distinct from the epitope
specificity of human PR3-ANCA. This suggests that the immune response against
PR3 in rabbit develops differently than in humans. Thrs fact should be taken into
consideration especialll' rvhen rabbit anti-PR3 antibodies are used to detect human
PR3.
The study described in Chaptet 5 started from the hypothesis that, in WG patients,
the presence of PR3 on the surface of non-stimulated neutrophils enables interaction
with PR3-ANCA and influences c[nical manifestations of the disease. Onginally,
PR3 was found to be stored in azurophil granules of the neutrophil only, and was
believed to translocate to the neutrophil surface upon priming with TNFct. A recent
study using immunoelecton microscopy showed, however, that PR3 local-izes also in
the specific gtanules, secretory vesicles, and, even more interestingly, can be present
also on the surface of resting neutrophils (membrane PR3 or mPR3). PR3 can be
detected either on the total neutrophil population or on a subset of neutrophils. The
existence of mPR3 and mPR3* neutrophil subpopulations within one individual,
called bimodal expression of PR3, has been suggested to be geneticaiiy determined,
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since the proportion of mPR3+ neutrophils is individually highly stable. The
observation, that the mPR3" neutrophil subset tends to be larger in patients suffering
from vasculitis than in healthy individuals, led us to the hypothesis that an increased
number of mPR3* cells could be a dsk factor for relapse in this disease. We analyzed
mPR3 expression on resting neutrophils in large groups of healthy controls and WG
patients in complete remission and related it to clinical manifestations and to the
suscepubility to develop relapses. Although the number of patients wrth a bLmodal
mPR3 expression did not drffer between patients and controls, WG patients had an
increased percentage of mPR3+ neutrophils and an elevated level of mPR3
expression compared with healthy individuals. Within the group of WG patients, an
elevated level of mPR3 expression was significantly associated with an increased risk
for relapse and wtth an increased relapse rate, but not with the disease extent or
particular manifestations at diagnosis or at telapse. We suggest that neutrophils of
the mPR3+ phenotype are more susceptible to activation by PR3-ANCA than mPR3
neutophils because the autoantigen is directly accessible on the cell surface, also
without priming. As a result, increased numbers of mPR3* neutrophils andf or an
increased level of mPR3 expression might be associated with more severe disease.
The functional signif,rcance of membrane PR3 expression fot neutrophil activation
induced by PR3-ANCA was investigated rn the study described in Chapter 6. We
stimulated resting and TNFcr-primed neutrophils with monoclonal antr-PR3
antibodies and measured eady and late functional responses using two different read-
out systems, namely actin poiymerization and oxidative burst, respectively.
Additionally, we investigated the influence of TNFo on mPR3 expression. TNFo
caused upregulation of membrane PR3 compared to resting neutrophils and, in
neutrophils drsplaying a brmodal mPR3 expression, influenced both subsets to a
comparable degree without changing the petcentages of cells present within these
subsets. This further supports the hypothesis on the genetic background of the
pattern of mPR3 expression. The most important observation from this study is the
fact that the degtee of actin polymerization, but not the level of oxidative burst in
response to anti-PR3 antibody, correlates vdth the level of PR3 expression on the
neutrophil surface. The anti-PR3 antibody-induced oxidative burst is pnmrng-
dependent and i.ndependent of the pattem of PR3 expression. There are inter-
individual differences in the concentration of anti-PR3 antibody inducing the
maximal response. However, the amount of intracellulat reactive oxygen species
produced in response to antr-PR3 antibody does not correlate with mPR3 expression
on primed neutrophils. Shordy, our results strongly suggests that the presence of
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PR3 on non-primed neutrophils is not sufhcient for the anti-PR3-antibody-induced
oxidative burst. In contrast to the oxidative burst measured 30-60 minutes aftet
stimulation, actin polymerization measuted vithin 10-30 seconds after anti-PR3
antibody administration is prirning-independent and strongly corelated vdth the
level of PR3 present on the surface of resting neutrophils, but not uiith the pattem of
mPR3 exptession (monomodal / bimodal). Since there is a conelation between the
ievel rnPR3 exptession and the level of the early response of neutrophils to
stimulation by anti-PR3 antibody, it is possible that, in uiuo, the presence of PR3 on
the surface o[ resting neutrophils has implicatrons for neutrophil susceptibility to
activation by PR3-ANCA. This gives, at least a partial, explanat.i.on for the
obserwat-ion that PR3-ANCA positrve patients with WG, who have a high expression
of PR3 on resting neutrophils, are more susceptible to develop relapse than patients
with lorv membrane PR3 exoression.
In Chapter 7 we summanze the current knowledge on neutrophil activation by
ANCA in systemic vasculitis. We discuss the binding of ANCA to their antigens,
namely PR3 and MPO, and to Fcy receptors on the neutrophil surface, and the role
of these interactions in tdggering of the functional responses. We address the
importance of TNFcr ptrming for up-regulation of surface molecules involved in
activation by ANCA, and we focus on the factors determining the susceptibiliry of
neuttophils to this activation. Next, we describe the signal ttansduction pathways
involved in activation of neutrophils by monomeric ANCA as well as by ANCA-
containing immune complexes. Although these srgnaling routes have not been fully
dissected yet, there is accumulating evidence that spacial interactions of muluple
molecules, includrng Fc1 receptors, Bz-integtins, and, possibly, ANCA antigens in
'activation clusters' or 'rafts' may define the signal trig;ered by ANCA. Finally, we
summarize the contribution of neutrophils activated by ANCA to tissue injury in uiuo
and u/e describe the consequences of activation for the fate of the neutroohil.
General conclusions
In tlris thesis we tried to analyze interactions between PR3-ANCA and its target
antigen in the context of activation of neutrophils in ANCA-associated small vessel
vasculitis.
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The Ftst part, devoted to characterization of PR3-ANCA epttope speciFrcity,
provides some neu/ insights into the background of the longrtudinal changes in the
functional properties of PR3-ANCA. Epitope shift ftom a disease-inducrng epitope
to other areas of the autoantigen dudng the course of the disease may be tesponsible
for the initiation and progression of WG, as has been suggested fot other
autoimmune diseases such as SLE. It would explain how some functional properties
of PR3-ANCA, such as interference with the proteolytic activity of PR3 and with
binding of the PR3 inhibitor ct,1-antitrlpsin (crr-AT) to PR3, may change between
active and quiescent phases of the disease. One of the remaining questions to be
answered in the future is why and how the autoimmune response against PR3 is
nggered. Taking into account our observation of intta-molecular changes in PR3-
ANCA epitope specifrcity, it cannot be excluded that mechanisms such as moleculat
mimicry may be instrumental in the initiation of PR3-ANCA production. It is
conceivable that, on a particular genetic backgtound, an otdinary immune response
against an as yet unidentified bacterial or viral protein mrght lead to the synthesis of
antibodies cross-reacting with PR3 (inter-molecular epitope spreading) and by intra-
molecular epitope shift turn into pronounced autoimmune responses against this
pfoteln.
Comparison of the petformance of a recombinant baculovrrus PR3 and native PR3
in ELISA brought us to two important conclusions. First, the recombinant PR3
tested in our study is a promrsing alternative for native PR3 and, after extended
optimization and validation of the assay, may be useful for PR3-ANCA detectron in
patients with systemrc vasculitis. Impottandy, the choice of the captunng anti-PR3
antibody is one of the factors determining the results of capture ELISA. Second, it
should be stressed that, despite an appatently close similarity of native PR3 and
recombinant PR3, these two forms of PR3 are not identical.
The second part of this thesis focuses on the implications of PR3 accessibility on the
neutrophil surface for the susceptibilrty of these cells fot activation by PR3-ANCA.
Our observations, both in uiuo and in uitro, support the hypothesis that the level of
PR3 expression on the cell sutface determines 'activatability' of resting neutrophils in
PR3-ANCA-positive individuals. A high PR3 exptession on the surface of resting
neutrophils in patients with WG seems to be a risk factor for recurrent disease and,
in the presence of PR3-ANCA, may have important implications for eady
cytoskeletal changes in the neutrophil, even without necessity of pnmrng. Since both
the pattern and the level of mPR3 expression have been suggested to be genetically
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determined, it further supports the hypothesis on the involvement of genetic factors
in the pathophysiology of WG.
In conclusion, these studies have contributed to the understanding of the role of
PR3 and PR3-ANCA in WG. They show evidence for intra-moleculat changes in
PR3-ANCA which may explain changes in the functional properties of these
autoantibodies. Furthermote, they demonstrate the consequence of PR3 expression
on the cell surface for neutrophil activation and stress the role of this expression as,
possibly, one of the genetically determined risk factors for the development of
systemic vasculitis.
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